Live Breaking News & Updates on Biopark regensburg

Stay updated with breaking news from Biopark regensburg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lysando AG and Amicogen Inc. Sign General Development Agreement

Lysando AG market leader in the field of antimicrobial proteins has signed a general development agreement with Amicogen Inc., a publicly traded biotechnology company and CDMO headquartered in South

Jinju , Kyongsang-namdo , South-korea , Regensburg-biopark , Kostenloser-wertpapierhandel , Verena-schossmann , Biopark-regensburg , Lysando-innovations-lab-gmb , Amicogen-inc , Count-markus-matuschka-de-greiffenclau , Lysando-innovations-lab-gmbh , Lysando

Dr. Fabian Geldmacher is Director Strategy & Business Development of Lysando AG

TRIESENBERG, Liechtenstein--(BUSINESS WIRE)--#Artilysin--Lysando AG – market leader in the field of antimicrobial proteins – is pleased to announce that Fabian Geldmacher, M.D., has joined the team as Director Strategy & Business Development in June. Dr. Geldmacher will be responsible for shaping Lysando's strategy...

Regensburg-biopark , Fabian-geldmacher , Biopark-regensburg , Life-sciences-practice , Lysando-innovations-lab-gmb , Strategy-business-development-on , Mckinsey-company , Director-strategy , Business-development , Associate-partner , Molecular-medicine , Count-markus-matuschka-de-greiffenclau

Wilhelm von Haller is Chief Financial Officer of Lysando AG

Lysando AG market leader in the field of antimicrobial proteins is pleased to announce that Wilhelm von Haller has joined the team as Chief Financial Officer this March. Baron von Haller is an expert

Regensburg-biopark , Kostenloser-wertpapierhandel , Verena-schossmann , Biopark-regensburg , Deutsche-bank-group , Lysando-innovations-lab-gmb , Chief-financial-officer , Corporate-finance , Deutsche-bank , Lysando-innovations-lab-gmbh , Wilhelm , Aller

Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim

TRIESENBERG, Liechtenstein--(BUSINESS WIRE)--#Artilysin--The market-leader for antimicrobial proteins, Lysando AG, has appointed Sang Jung Kim as new member to the Board of Directors. Kim has a strong Biotech background and a proven successful track record of more than 30 years experiences in relevant commercial are...

Seoul , Soult-ukpyolsi , South-korea , Lysando-artilysin , Asia-pacific , Jung-kim , Biopark-regensburg , Lysando-innovations-lab-gmb , Seoul-national-university , Animal-health , Technical-industries , Business-development